Categories

10000 to 4crs in 18 months 1000rs to 50crs 300% returns 75% promoter holdings A 50 bagger A sureshot 5 bagger Analysis Another fraud? Auto ancillaries Bank sector Blind sell Brand plays Broking Bse Nse Buy calls cements Ceramics/tiles Counters I don't like Debt free businesses Delisting candidates demerger bets Disclosure- I own them Domestic consumption plays E-Commerce pick Education Exit at rallies Famous analysts Famous stocks FMCG Footwear future multibaggers Gems andJewellery Hidden gems High conviction ideas High dividend plays High potential small caps High ROE stocks Holding companies Hotel sector How they looted you.. Indian stock market Infrastructure sector Interesting Microcaps IT KPO Landbank plays largecap ideas Less than 5 PE stocks Liquor Logistics Market lessons Market outlook for 2013 and 2014 Market underperformers Meeting with the CEO Metals Monopoly businesses My 5 baggers My Favourite counters My paid stock recommendations My stock picking techniques nse bse tips Oil exploration Operator calls Paints Penny stock outlook penny stock updates Pharma sector Poultry stocks PSU Publicity freaks Real estate Renewable energy plays Safe bets Sell recommendations Share market Live shipping stocks short term call SOTP plays stock tips stock under 10rs Stocks to watch out for Strong bonus candidates Takeover candidates TATA product tea Textiles The 13 bagger The 45 bagger Trading companies Transformers Turnaround bets Tyres Uncertain/Risky business models Unique businesses

Search This Blog(Over 800 companies covered in the blog).

Please note

Note: The artciles are not research reports but assimilation of information available on public domain and it should not be treated as a research report.

Registration status with SEBI: I am not registered with SEBI under the (Research Analyst) regulations 2014 and as per clarifications provided by SEBI: “Any person who makes recommendation or offers an opinion concerning securities or public offers only through public media is not required to obtain registration as research analyst under RA Regulations”

Disclosure: It is safe to assume that I might have the dkiscussed companies in my portfolio and hence my point of view can be biased.Readers should consult registered consultants before making any investments
.

Archives : Old artciles

Tuesday, August 7, 2012

Wockhardt Ltd :Paid call to members(Target achieved)

Many of you repeatedly in my mail have asked for paid calls and what they will be and all.Now as an amateur and being a social guy I would always safeguard the vested interest of investors than something else.The open blog is a place for me to give guidance.Paid blog is for the one who needs those calls and my bigtime guidance desperately.Anyways here"s an example of a paid member call and the type which I provided just an year back.

btw:Broking members(Members having an online trading account with my firm) by virtue of having a lifelong association enjoys the paid calls for free.

Market outlook and stock tip:-Wockhardt Ltd
Saturday, July 30, 2011

Scripscan:Wockhardt Ltd
Traded in:Nse-bse
Cmp:375
Medium term target:640
Return:86%
Duration:6 months
Long term target:1080(200% for a period of 12-15 months)

Story:Wockhardt is a high technology global pharmaceuticals and biotechnology major with innovative multi-disciplinary research and development programmes.It has 5 research centres and 21 world-class manufacturing plants in India, USA, UK, France and Ireland. Wockhardt has a multi-ethnic workforce of over 6500 people from 14 different nationalities.Wockhardt has presence in formulations,nutritional products and bulk drugs.Majority of its revenues come from the international markets.The company has been a great performer barring the last few years when it got saddled with debts.The company finally made a turnaround with 90crs of consolidated profit for fiscal fy10-11.The debt issue is still lingering with its FCCB holders where the company owes 440crs,hearing being on 1st of august.According to the market speculation the same should get settled this time around which would rerate the stock bigtime.The company overall is still having 3000crs of debts in book(including to the bond holders)but it has come up with a solid restructuring plan.Under recent corporate debt restructuring measures, the company has been given a few more years to payback its debt to the secured lenders, who account for almost 90% of its debt.Another big positive trigger for the stock can be its nutrition division where its in advanced stage of selling the business to either danone or abbot for a massive 1350crs.Once the deal happens wockhardt would have a new lease of life with debt being under control helping it to boost its margins.The company really shocked me with its 4th quarter results where it came out with nearly 940crs of sales and 162crs consolidated profit after tax.Even assuming nil growth quarter on quarter for the coming four quarters we get a Profit figure of 650crs for fy11-12.That results in an earning per share of 60rs.Topline pharma companies like lupin,ranbaxy,sun pharma quotes at 20 times plus forward.Wockhardt is massively undervalued with a strong business and great potential forward.Lupin has a marketcap of 20000crs,ranbaxy attracts 23000crs,sun pharma a slightly bigger one has a 50000crs+ marketcap as on last closing(wockhardt on the other hand trades at less than 5000crs marketcap).I have no clue on monday's court hearing but even if we forget that chapter wockhardt has a robust future.To me its fair value is above 1000 rs(have assigned a target of 1080rs) and the same should be achieved within the next 4-5 quarters.At 375 bucks its a massive steal.Be it for short or long term the company should rock and give a huge northward jerk to your portfolio.Altogether a gem of a buy at present levels.

Todays update:In just a matter of 1 year, the company has hit the 200% return target of 1080 rs and looks good for even more.From 375 bucks to 1080 rs in just a matter of 12 months.Enjoy the ride members.

Regards,
ARUN
I can be reached at:arunsharemarket@gmail.com

No comments:

Important Disclaimer&Privacy policy

This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
 
x

Subscription to Arunthestocksguru

Enter your email address:

Delivered by FeedBurner